Cyclooxygenase-2, player or spectator in cyclooxygenase-2 inhibitor-induced apoptosis in prostate cancer cells

Journal of the National Cancer Institute

Volumn 94, Issue 8, 2002, Pages 585-591

  Song, Xueqin ^a   Lin, Ho Pi ^b   Johnson, Amy J ^a   Tseng, Ping Hui ^b   Yang, Ya Ting ^b   Kulp, Samuel K ^b   Chen, Ching Shih ^a,b  

^a University of Kentucky   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; 5 BROMO 2 (4 FLUOROPHENYL) 3 (4 METHYLSULFONYLPHENYL)THIOPHENE; ANDROGEN; CELECOXIB; COMPLEMENTARY DNA; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; DOXYCYCLINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOCORTIN 5; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PHOSPHATIDYLSERINE; PROSTAGLANDIN E2; ROFECOXIB; TETRACYCLINE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG SYNTHESIS; ENZYME INHIBITION; HUMAN; HUMAN CELL; HYPOTHESIS; IC 50; MALE; MOLECULAR BIOLOGY; MOLECULAR CLONING; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; SENSITIVITY ANALYSIS; STRUCTURE ACTIVITY RELATION;

EID: 0037123345     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/94.8.585     Document Type: Article

References (30)

1. 2 in human colon cancer cells
2. NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells
3. Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis
4. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis
5. Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway
6. Sulfone metabolite of sulindac inhibits mammary carcinogenesis
7. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: Insight into mechanisms and implications for cancer growth and ulcer healing
8. Host cyclooxygenase-2 modulates carcinoma growth
9. Malignant transformation and antineoplastic actions of nonsteroidal antiinflammatory drugs (NSAIDs) on cyclooxygenase-null embryo fibroblasts
10. The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2
11. Cancer research. Anti-inflammatories inhibit cancer growth-but how?
12. Cyclooxygenase gene expression in inflammation and angiogenesis
13. Cyclooxygenase in biology and disease
14. Cyclooxygenase-2 inhibitors in tumorigenesis
15. Cyclooxygenase-1 and -2 isoenzymes
16. Cyclooxygenase-2 and carcinogenesis
17. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2
18. G1 delay in cells overexpressing prostaglandin endoperoxide synthase-2
19. Cyclooxygenase-2 expression inhibits trophic withdrawal apoptosis in nerve growth factor-differentiated PC12 cells
20. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)
21. Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice
22. Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell lines
23. Tumorigenic transformation of immortalized ECV endothelial cells by cyclooxygenase-1 overexpression
24. Overexpression of cyclooxygenase-2 induces cell cycle arrest. Evidence for a prostaglandin-independent mechanism
25. Apoptosis signaling pathways mediated by cyclooxygenase-2 inhibitors in prostate cancer cells
26. Prostaglandin J2 and 15-deoxy-delta 12,14-prostaglandin J2 induce proliferation of cyclooxygenase-depleted colorectal cancer cells
27. Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: Identification if 4-[5-(4-methylphenyl)-3 -(trifluoromethyl)-1H-pyrazol-1-y1]benzenesulfonamide (SC-58635, celecoxib)
28. Intracellular unesterified arachidonic acid signals apoptosis
29. PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs
30. The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta